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Swine inﬂuenza caused by inﬂuenza A virus is one of the most
important infectious diseases in pigs. To date, there are 16 hemagglu-
tinin (HA) and9neuraminidase (NA) subtypes of inﬂuenzaAvirus, all of
whichhave been isolated fromaquatic birds (Alexander, 2000; Fouchier
et al., 2005;Webster et al., 1992). Inﬂuenza Avirus can also infect a large
variety of mammalian species including humans, horses, dogs, cats, and
sea mammals. Because host range is restricted, only certain subtypes of
inﬂuenza A virus have been established and maintained in mammalian
species; for example, only three subtypes (i.e., H1N1, H3N2, and H1N2)
of inﬂuenza A viruses are consistently isolated from pigs worldwide.
Pigs have been suggested to play an important role in transmission
betweenbirds andhumansbyacting as the “mixing vessel” for inﬂuenza
viral reassortment (Ma et al., 2009; Scholtissek, 1994) because of the
species' susceptibility to infectionwith both human and avian inﬂuenza
viruses. This susceptibility may be due to the fact that porcine tracheal
cells have viral receptors for mammalian and avian viruses (Ito et al.,
1998).With the recent introduction of genes from human and avian
inﬂuenza viruses into swine inﬂuenza viruses (SIVs), the major viruses
now circulating through North American swine herds are triple-
reassortant viruses (i.e., H3N2, H1N1, and H1N2). These triple-reassor-
tant SIVs have similar, conserved triple-reassortant internal genes,
including the avian PA and PB2 polymerase genes, the human PB1
polymerase gene, and the swine nucleoprotein (NP), matrix (M), and
nonstructural protein (NS) genes. The novel avian/human polymerase
complex encoded by these genes can accept multiple HA and NA types
andmay endow a selective advantage to SIVs. The recently characterized
novel swine H2N3 and swine human-like H1 viruses are examples of
viruses that demonstrate the ﬂexibility of the avian/human polymerase
complex to accept various HAs and NAs (Ma et al., 2007; Vincent et al.,
2009). The 2009 pandemicH1N1 virus is a reassortant virus that contains
NA and M genes from Eurasian SIVs and the other 6 genes from North
American triple-reassortant SIVs (Smith et al., 2009). The common
feature of the pandemic H1N1 and North American triple-reassortant
viruses is that these viruses have a novel polymerase complex (i.e., avian
PA and PB2 and human PB1).
The polymerase complex is responsible for transcription and
replication of the viral genome and is a major determinant of host
range and pathogenicity (Naffakh et al., 2008; Neumann and Kawaoka,
2006). A single residue at position 627 in the PB2 protein is largely
responsible for determining host range and pathogenicity of inﬂuenza
viruses (Hatta et al., 2001; Subbarao et al., 1993). PB2 that is derived
from human inﬂuenza viruses usually possesses a lysine (K) at position
627 whereas that derived from avian inﬂuenza viruses predominantly
Fig. 1. Characterization of reassortant and PB2 single-substitution viruses in vitro.
(a) Plaque size in MDCK cells 2 days after infection; (b) virus growth in MDCK cells at
different time points. The results are representative of four independent experiments
and values represent the log10 geometric mean TCID50/ml±SEM (*Pb0.05; **Pb0.01;
***Pb0.001).
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American SIVs, almost all pre-1998 isolates are classical H1N1 viruses
containing PB2 627K whereas most post-1998 isolates are triple-
reassortant H1N1 or H3N2 viruses containing PB2 627E (Bussey et al.,
2010). The pandemic H1N1 virus contains E at position 627 of its PB2
protein (Garten et al., 2009). It is unclear how the avian PB2with 627E in
SIVs affects viral replication, pathogenicity, and interspecies transmission.
In this study, a reassortant virus (i.e., 1930-Tx/98PB2-627E) was
generated by reverse genetics in the genetic background of the classical
H1N1A/Swine/Iowa/15/30 (1930) virus,which carries the PB2 gene from
an H3N2 triple-reassortant A/Swine/Texas/4199-2/98 (Tx/98) virus. The
PB2 gene of the Tx/98 virus is avian in origin (Zhou et al., 1999). In
addition, reassortant viruses (1930-Tx/98PB2-627K, 1930-PB2-627E)
with a single amino acid (aa) substitution at position 627 in the avian-
origin or swine-origin PB2 were generated. The growth properties and
pathogenicity proﬁles of reassortant viruses carrying avian-origin or
swine-origin PB2 with 627 E or K were evaluated in vitro and in vivo.
Results
Growth Characteristics of the Wild-type and Reassortant Viruses
The avian-origin Tx/98 PB2 shows 96.8% homology at the
nucleotide level and 95.5% homology at the aa level with the swine-
origin 1930 virus PB2. There are 34 aa difference between the avian-
origin Tx/98 and swine-origin 1930 PB2 proteins (Table 1). The
reassortant 1930-Tx/98PB2-627E and 1930-Tx/98PB2-627K viruses
formed similar size plaques as the wild-type 1930-PB2-627K virus
did; however, the 1930-PB2-627E virus with the single substitution at
position 627 formed smaller plaques than the other three viruses did
(Fig. 1a). In MDCK cells, the virus carrying the avian-origin PB2 gene
with 627K (1930-Tx/98PB2-627K) grew to signiﬁcantly higher titers
(Pb0.05) than did the respective virus with PB2 627E (Fig. 1b).
Similarly, the virus containing the swine-origin PB2 gene with 627K
(1930-PB2-627K) grew to signiﬁcantly higher titer (Pb0.05) than did
the respective virus with the swine-origin PB2 627E except for the
time point 36 h post-inoculation (Fig. 1b).
Mouse Pathogenicity of Reassortant SIVs with PB2 Mutations
Mice inoculated with 1930-Tx/98PB2-627K or the wild-type 1930-
PB2-627K virus developed clinical disease (i.e., weight loss, dyspnea,
rough fur, and lethargy); this disease resulted in death of most of the
inoculated mice (Table 2). Mice inoculated with the 1930-Tx/98PB2-
627E virus containing the avian-origin PB2with 627E developed similar
clinical illnesses butwithoutmortality. In contrast,mice inoculatedwith
the 1930-PB2-627E virus did not show any clinical signs and appeared
similar to themock-inoculatedmice.Mice in either the 1930-Tx/98PB2-
627E group or the 1930-Tx/98PB2-627K groups who survived the
infections did not fully recover from themby the end of the experiment.
Compared to mock-inoculated controls, four inoculated groups had
signiﬁcantly greater (Pb0.05) microscopic lung lesions (Table 2). The
1930-PB2-627K, 1930-Tx/98PB2-627K and 1930-Tx/98PB2-627E
caused signiﬁcantly greater microscopic lung lesions (Pb0.05) thanTable 1
Comparison of the avian-origin Tx/98 and swine-origin 1930 PB2 at the amino acid level.
22a 64 65 66 82 114 122 136
Tx/98 PB2 K M D M N V V R
1930 PB2 R I E T S I A G
421 467 468 475 478 480 539 588
Tx/98 PB2 V M I L I V I T
1930 PB2 I L T M V I V A
a Position of the amino acid.did the 1930-PB2-627E (Table 2). No signiﬁcant difference in micro-
scopic lung lesion was evident between the 1930-Tx/98PB2-627K-
inoculated mice and the 1930-Tx/98PB2-627E-inoculated mice
(Table 2). Although viral RNA was detected in the lung homogenate
fromeach infectedmouse, viruswasonly isolated fromthe lungs ofmice
inoculated with the wild-type 1930-PB2-627K (mean virus
titer=103.97 TCID50) and from the lungs of 9 mice inoculated with
1930-Tx/98PB2-627K (mean virus titer=102.83 TCID50). The viral RNA147 184 199 225 243 265 271 312 382
T T A G M N A E I
I M S S L S T K V
590 591 627 637 645 660 661 684 702
S R E T L K A A K
G Q K A M R T T R
Table 2
Mortality and lesions in mice inoculated with PB2 single-substituted or parental
viruses.
Virus Mortalitya Average no. of days
p.i. until deathb
Histopathologic
score (0–3)c
wild-type 1930-PB2-627K 8/10d 7.80±1.09d 2.75±0.34d
1930-PB2-627E 0/10d 14.00±0.00d 1.10±0.21d,f,g
1930-Tx/98PB2-627E 0/10e 14.00±0.00e 2.05±0.24f
1930-Tx/98PB2-627K 9/10e 7.30±0.86e 2.30±0.26g
Control 0/10 14.00±0.00 0.00±0.00
a Mortality=number of mice that died after challenge/total number of mice in
group.
b Values are the mean±SEM.
c Values are the mean±SEM.
d Signiﬁcant difference between 2 groups (Pb0.05).
e Signiﬁcant difference between 2 groups (Pb0.05).
f Signiﬁcant difference between 2 groups (Pb0.05).
g Signiﬁcant difference between 2 groups (Pb0.05).
3W. Ma et al. / Virology 410 (2011) 1–6at time of necropsy/death measured in the lungs of mice infected with
PB2-627K (i.e., 1930-PB2-627K and 1930-Tx/PB2-627K) groups was
106-fold higher than that in the lungs of mice infected with PB2-627E
(i.e., 1930-PB2-627E and 1930-Tx/98PB2-627E) groups (data not
shown). Sequence analysis showed that position 627 (E or K) of the
PB2 protein of respective viruses isolated from infected mouse lungs
represents the same amino acid as the challenge viruses, indicating this
speciﬁc amino acid is stable for at least one in vivo passage.
Pig Pathogenicity of Reassortant SIVs with PB2 Mutations
No acute respiratory signs were observed in either pig challenge
experiment. Necropsy revealed macroscopic lung lesions (i.e., plum-
colored, consolidated areas) in all virus-inoculated pigs but none in the
mock-inoculated control pigs (Table 3). On day 3 p.i., there was no
statistically signiﬁcant difference in the extent of macroscopic lung
lesions among any of the virus-inoculated groups; however, viruses
with swine-origin PB2 induced more extensive macroscopic lesions on
average than did the viruses with avian-origin PB2 gene. On day 5 p.i.,
the 1930-PB2-627K group had signiﬁcantly greater (Pb0.05) lung
lesions than did the 1930-PB2-627E and 1930-Tx/98PB2-627K groups,
but there was no signiﬁcant difference between the lesions of the 1930
virus with avian-origin PB2 (i.e., avian-origin PB2 627K and 627E)
groups (Table 3). On day 3 p.i., viruses carrying either the avian-origin
PB2 627K (1930-Tx/98PB2-627K) or the swine-origin PB2 627K (1930-
PB2-627K) replicated more efﬁciently (i.e. to higher titer) in pigs' lungs
than did the virus containing the swine-origin PB2 627E (Pb0.01);
however, there were no signiﬁcant differences found on day 5 p.i.
(Table 3). No signiﬁcant difference on virus titers in pigs' lungs wasTable 3
Virus titers in BALF and macroscopic and microscopic lung lesions in inﬂuenza virus-inocul
Virus Virus titer in BALF (TCID50/ml)a Lu
Day 3 p.i. Day 5 p.i. D
Avian-origin PB2
Mock 0.00±0.00 0.00±0.00
1930-Tx/98PB2-627E 3.76±0.51 3.92±0.48 1
1930-Tx/98PB2-627K 5.17±0.55e 3.65±0.17 1
Swine-origin PB2
Mock 0.00±0.00 0.00±0.00
1930-PB2-627E 2.96±0.14c,e 3.99±0.30 2
wild-type 1930-PB2-627K 4.25±0.41c 4.39±0.10 2
a Values represent the log10 geometric mean BALF TCID50/ml±SEM.
b Values represent the mean±SEM.
c There is a signiﬁcant difference between the 2 groups (Pb0.05).
d There is a signiﬁcant difference between the 2 groups (Pb0.05).
e There is a signiﬁcant difference between the 2 groups (Pb0.05).
f There is a signiﬁcant difference between the 2 groups (Pb0.05).found between 1930-Tx/98PB2-627K and 1930-Tx/98PB2-627E viruses
ondays 3 and5 p.i. (Table 3). Lungs fromvirus-inoculatedpigs thatwere
euthanized on day 3 p.i. or day 5 p.i. exhibited mild to moderate
interstitial pneumonia and acute to subacute necrotizing bronchiolitis
with slight lymphocytic cufﬁng of bronchioles and vessels. Only one
(20%, 1/5) nasal swab collected from a pig inoculatedwith the 1930-Tx/
98PB2-627K virus on day 5 p.i. was positive for virus isolation and no
virus was detected in other nasal swab samples collected on days 3 and
5 p.i. from any virus challenge groups in either experiment (data not
shown). Sequence analysis showed that position 627 (E or K) of the PB2
protein of viruses isolated from nasal swab and BALF samples collected
from infected pigs represents the same amino acid as the challenge
viruses.
Discussion
Avian PB2 with 627E was introduced into North American SIVs
more than 10 years ago, and this avian signature (i.e., 627E) remains
stable rather than changing to the mammalian signature (i.e., 627K).
In this study, we found that the PB2 protein with aa 627K is a key
determinant for efﬁcient viral replication in MDCK cells and for
virulence in mice. These ﬁndings conﬁrm previous results showing
that PB2 627K is essential for virulence of the 1997 H5N1 and other
highly pathogenic H5N1 avian inﬂuenza viruses in mice (Hatta et al.,
2001; Liu et al., 2005).
The virus containing the avian-origin PB2 with 627E was able to
infect mice and pigs, indicating that other important aa mutations can
compensate for the absence of 627K in the PB2 protein as reported
previously (Li et al., 2009). Our sequence comparison of PB2s from the
Tx/98 and 1930 viruses with those from mouse-adapted viruses
revealed that both Tx/98 and 1930 PB2s contain the same aa at
positions 333T, 482K, 701D, and 714S, which are completely different
from the conserved PB2 aa signatures (i.e., 333I, 482A, 701N, and
714R) normally required in mouse-adapted viruses (Naffakh et al.,
2008), suggesting that other mutations can also confer adaptation of
the avian-origin PB2 to mice and other mammalian species. Normally,
the avian-origin PB2 contains E at aa position 627 and alanine (A) at
aa position 271, whereas the swine-origin PB2 contains K and
threonine (T) at those respective positions (Bussey et al., 2010;
Naffakh et al., 2008). The avian PB2 271A residue plays a key role in
enhanced polymerase activity and viral growth of inﬂuenza A viruses
in mammalian host cells and likely contributes to virus spread and
cross-species transmission of pandemic H1N1 viruses (Bussey et al.,
2010). Therefore, PB2 271A might compensate for the presence of
627E in the 1930-Tx/98PB2-627E virus and in currently circulating
SIVs. The avian-origin PB2 in the currently circulating SIVs and in the
pandemic H1N1 viruses contains a conserved serine (S) at positionated pigs.
ng lesion score (%)b Histopathologic score (0–3)b
ay 3 p.i. Day 5 p.i. Day 3 p.i. Day 5 p.i.
0.00±0.00 0.00±0.00 0.40±0.40 0.40±0.24
5.97±4.46 14.01±3.10 2.90±0.40 2.60±0.51
6.40±3.37 9.97±2.17f 2.60±0.40 2.50±0.45
0.00±0.00 0.00±0.00 0.70±0.12 0.60±0.19
3.31±4.13 10.26±2.29d 2.40±0.19 2.30±0.30
4.49±4.08 22.29±5.46d,f 3.00±0.16 2.90±0.10
4 W. Ma et al. / Virology 410 (2011) 1–6590 and a conserved arginine (R) at position 591, called the SR
polymorphism, which increases polymerase activity and viral repli-
cation in human and porcine cells if present with PB2 627E (Mehle
and Doudna, 2009). This SR polymorphism is considered to be an
adaptive strategy of the avian inﬂuenza virus polymerase for
replication in humans (Mehle and Doudna, 2009). Because the Tx/
98 avian-origin PB2 contains this SR polymorphism, it could
contribute to both mammalian adaptation and disease-causing
capabilities of the 1930-Tx/98PB2-627E virus.
In pig challenge experiments, the 1930 viruses with PB2 627K (i.e.,
1930-Tx/98PB2-627K and 1930-PB2-627K) were able to replicate in
pig lungs and induce severe macroscopic and histopathologic lung
lesions whether in the avian-origin or swine PB2 background.
Additionally, when the classical 1930 virus contains an avian-origin
PB2, either 627K or 627E allow for pathogenicity in the pigmodel. This
result is different from our data in the mouse model and from a
previous study that 627K in the H5N1 avian PB2 polymerase is crucial
for replication in pigs (Manzoor et al., 2009). Our comparisons of the
histopathologic lung lesions and virus titers caused by each virus
revealed that the 627E residue of PB2 decreases the pathogenicity of
the classical 1930 virus in pigs when it contains the swine-origin PB2
but not when it contains the avian-origin PB2.
Thus, the importance of the aa at position 627 in PB2 appears to
differ among different virus strains and in different animal species.
These results correlate with previous observations in which substi-
tuting the E at position 627 in PB2 with K does not change virus
replication and virulence of the 2009 pandemic H1N1 virus in mice
(Herfst et al., 2010; Zhu et al., 2010) or the pathogenicity and
transmission of the virus in ferrets (Herfst et al., 2010). Furthermore,
although the majority of the lethal H5N1 viruses for ferrets and mice
possess PB2 627K, some H5N1 viruses with PB2 627E are lethal in
ferrets (Katz et al., 2000; Maines et al., 2005; Salomon et al., 2006).
Whether PB2 is derived from swine or avian inﬂuenza viruses, 627K of
PB2 is crucial for virulence of the classical H1N1 SIV in the mouse
model. In the pig model, PB2 627E decreases pathogenicity of the
classical 1930 SIV when it contains the swine-origin PB2, but not
when it possesses the avian-origin PB2. Our study suggests that the
pathogenicity of SIVs with different PB2 genes and mutation of codon
627 inmice does not correlate with the pathogenicity of the same SIVs
in the natural host, the pig.
Materials and Methods
Cells and Eggs
Human embryonic kidney (HEK)-293T cells were maintained in
Opti-modiﬁed Eagle's medium (MEM) supplemented with 10% fetal
calf serum (FCS) (HyClone; Logan UT) and 1% antibiotics (Invitrogen;
Carlsbad, CA), and Madin-Darby canine kidney (MDCK) cells were
maintained in Dulbecco's MEM (DMEM) with 5% FCS, L -glutamine
(Invitrogen), MEM vitamins (Invitrogen), and 1% antibiotics (Invitro-
gen). Cells were inoculated with the respective viruses in MEM
infecting medium containing 0.3% bovine albumin (Sigma; St. Louis,
MO), 1 μg/ml TPCK-treated trypsin (Sigma), L-glutamine, MEM
vitamins, and 1% antibiotics (Invitrogen). Ten-day-old embryonated
chicken eggs were inoculated with virus via the allantoic cavity for
viral ampliﬁcation.
Construction of Mutated PB2-containing Plasmids
To change the aa at position 627 of avian-origin PB2 (Tx/98) from E
to K, the GeneTailor Site-Directed Mutagenesis system (Invitrogen)
was used according to the manufacturer's recommendations. Brieﬂy,
100 ng pHW-Sw-PB2 containing the PB2 gene from the Tx/98 virus
(Solorzano et al., 2005) was methylated by incubating it with DNA
methylase at 37 °C for 1 h, and then it was ampliﬁed in a mutagenesisreaction with a pair of overlapping primers (i.e., Tx/98-PB2 627K-Fw
and Tx/98-PB2 627K-Rw) (primer sequences are available upon
request). The mutagenesis mixture (2 μl) was used to transform
competent Escherichia coli cells, and plasmids were prepared using
the Qiagen Plasmid Mini kit (Qiagen, Valencia, CA). The mutation of
the resulting plasmid (i.e., pHW-Sw-PB2-627K) was conﬁrmed by
sequencing.
To change the aa at position 627 of the swine PB2 (i.e., 1930) from
K to E, 2 PCR reactions for PB2 were performed using the universal
forward PB2 primer (Hoffmann et al., 2001) and the reverse PB2
mutation primer, which contains the mutated nucleotide; pDZ-PB2
containing the PB2 gene from the 1930 virus was used as a template
(or the forward PB2 mutation primer containing the mutated
nucleotide and the universal reverse PB2 primer were used) (primer
sequences are available upon request). The full-length PB2 was
ampliﬁed by using PB2 universal primers and 2 partial PCR products
as templates. The full-length PB2 was partially digested by Bsa I (NEB,
Ipswich, MA) and then cloned into the BsmB I (NEB) sites of a
pHW2000 vector. The mutation of the resulting plasmid (i.e. pHW-
PB2-627E) was conﬁrmed by sequencing.
Generation of Wild-type 1930, Reassortant and PB2 Mutated Viruses
An eight-plasmid (i.e., pDZ-HA, -NA, -PB1, -PB2, -PA, -NP, -M, and
-NS) reverse-genetics system was used to generate the wild-type
1930 virus as previously described (Ma et al., 2010). To rescue the
1930 (i.e., 1930-PB2-627K) virus with a PB2 mutation from K to E at
position 627, pHW-PB2-627E was used to replace pDZ-PB2. The
reassortant virus (i.e., 1930-Tx/98PB2-627E) carrying the avian-origin
PB2 gene from the Tx/98 virus in the genetic background of the 1930
virus was rescued by using the pHW-Sw-PB2 replacing pDZ-PB2. To
generate the 1930-Tx/98PB2 (1930-Tx/98PB2-627E) virus with an E
to K substitution at codon 627 of PB2, pHW-Sw-PB2-627Kwas used to
replace pDZ-PB2. The sequence of each rescued reassortant viruses
was conﬁrmed, and each challenge virus was diluted inMEM to a ﬁnal
concentration of 105 50% tissue culture infective dose (TCID50).
Analysis of Viral Replication
To analyze viral replication efﬁciency, a monolayer of MDCK cells
in 6-well plates was inoculated with each virus at a multiplicity of
infection (MOI) of 0.01. Supernatant from infected cells was collected
at different time points. Virus titer was determined by inoculating
conﬂuent monolayers of MDCK cells in 96-well plates as previously
described (Richt et al., 2003), and the TCID50 per milliliter was
calculated for each sample by the method of Reed and Muench
(1938).
Experiments in Mice
To compare the relative virulence of the different reassortant viruses
in mice, experiments were conducted using 6- to 7-week-old Balb/c
mice at the National Animal Disease Center (NADC), Ames, Iowa.Mouse
experiments were conducted in compliance with the NADC's Institu-
tional Animal Care and Use Committee. Fifty mice were randomly
allocated to 5 treatment groups.Micewere anesthetizedwith isoﬂurane
USP (Phoenix Pharmaceutical, Inc.; St. Joseph, MO) and intranasally
inoculated with a 50 μl volume containing either virus-free MEM (i.e.,
negative control) or 105 TCID50 of a designated virus as depicted in
Table 2. Weights were recorded daily, and general health status was
observed twice daily. After the onset of disease, thegeneral health status
was observed thrice daily. Severely affected mice were euthanized
immediately, and all other mice were euthanized on day 14 post-
inoculation (p.i.). At necropsy, the right lung was stored at−80 °C for
later analysis, and the left lung was ﬁxed in 10% formalin for
histopathologic analysis. Virus detection was performed in a 10% tissue
5W. Ma et al. / Virology 410 (2011) 1–6homogenate in PBS that had been homogenized twice for 1 min in a
Mini BeadBeater-8 (Biospec Products; Bartlesville, OK). The homoge-
nate was centrifuged at 640 × g for 5 min, and the supernatant was
transferred to 1.5 ml reaction tubes for virus and RNA isolation. Real-
timeRT-PCRwas used to detect viral RNA as described previously (Richt
et al., 2004).
Experiments in Pigs
Four-week-old porcine reproductive and respiratory syndrome
virus- and SIV-negative pigs were used in this study, and all pig
experiments were approved by the Institutional Animal Care and Use
Committee at Kansas State University. The pathogenicity of viruses
containing avian-origin or swine PB2 with 627E or 627K was
investigated via two separate pig challenge experiments; the inocula-
tion protocol has been described previously (Richt et al., 2003). In the
ﬁrst experiment, 10 pigs were inoculated with 1930-Tx/98PB2-627E
and 10 with 1930-Tx/98PB2-627K. In the second experiment, 10 pigs
were inoculated with 1930-PB2-627K and 10 with 1930-PB2-627E. In
each experiment, 10 age-matched control pigs were mock-inoculated
with serum-free MEM.
Five inoculated pigs and 5 control pigs were necropsied on days 3
and 5 p.i. in each experiment. Nasal swabs were taken on days 0, 3,
and 5 p.i., placed in 2 ml MEM and stored at −80 °C. Blood was
collected from all pigs on days 0 and at the time of necropsy.
Bronchioalveolar ﬂuid (BALF) was obtained by lavage of each lung
with 50 mlMEM. Viral load in BALF was determined in a 96-well plate
as previously described (Richt et al., 2003). To determine virus
shedding, nasal swabs were tested for infectious virus by inoculating
10-day-old embryonated chicken eggs.
Lung Examinations of Experimental Pigs
At necropsy, lungs were removed in toto. A single experienced
veterinarian recorded the percentage of gross lesions on each lobe,
and a mean value for the seven lobes was calculated for each animal
(Richt et al., 2003). For histopathologic examination, tissue samples
from the trachea, the right cardiac lung lobe, and other affected lobes
were ﬁxed in 10% buffered formalin, processed, and stained with
hematoxylin and eosin. Lung sections were examined by a veterinary
pathologist in a blinded fashion and given a score of 0 to 3 to reﬂect
the severity of bronchial epithelial injury as described previously (Ma
et al., 2007; Richt et al., 2003).
Statistical Analysis
Macroscopic and microscopic pneumonia scores, mortality, and
average number of days p.i. until death were analyzed by using
analysis of variance (ANOVA) in GraphPad Prism version 5.0
(GraphPad software Inc. La Jolla, CA); a P-value of 0.05 or less was
considered signiﬁcant. Those response variables shown to have a
signiﬁcant effect by treatment group were subjected to comparisons
for all pairs by using the Tukey–Kramer test. Pair-wise mean
comparisons between inoculated and control groups were made
using the Student's t-test.
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